Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-052246
Filing Date
2024-12-27
Accepted
2024-12-27 16:00:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 488027
2 form424b3_001.jpg GRAPHIC 6238
  Complete submission text file 0001493152-24-052246.txt   498056
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283949 | Film No.: 241585698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)